1. AVASTIN® (bevacizumab) solution for intravenous infusion. Initial U.S. approval: 2004. Highlights of prescribing information,2015
2. EYLEA™ (aflibercept) injection for intravitreal injection. Initial U.S. approval: Highlights of prescribing information 2015,2011
3. Pharmacokinetics of ranibizumab in patients with neovascular age-related macular degeneration: a population approach;Xu;Invest Ophthalmol Vis Sci,2013
4. LUCENTIS® (ranibizumab injection). Intravitreal Injection; Initial U.S. approval: 2006. Highlights of prescribing information,2015
5. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012